More News
-
-
Comirnaty Bivalent Vaccine Arrives in Hong Kong SAR and Macau SAR and Will Soon Be Available to the Local Residents
2022-11-28(November 28, 2022, Shanghai, China) On November 26, 2022, Shanghai Fosun Pharma (Group) Co., Ltd.("Fosun Pharma", Stock Code: 600196.SH; 02196.HK) announced that the first batch of about 770,000 doses of the Comirnaty Original/Omicron BA.4/BA.5 bivalent vaccine (i.e. Comirnaty Original/Omicron BA.4-5 (15/15 micrograms)/dose Dispersion for Injection
-
-
Fosun Foundation: 10 Years of Dedication to Public Welfare, We Hope to Respond Quicker, Even Just by “0.01 Second”
2022-11-2222 November 2022, Shanghai,
-
-
BioNTech and Fosun Pharma Receive Emergency Use Authorization for Omicron-BA.4/BA.5 Adapted Bivalent Vaccine in Hong Kong and Special Import Authorization for Macau
2022-11-18Omicron BA.4/BA.5-adapted bivalent vaccine will become available in Hong Kong SAR and Macau SAR as a booster dose for individuals 12 years of age and olderBA.4/BA.5-adapted bivalent vaccine combines 15-µg of mRNA encoding the wild-type spike protein found in the original COVID-19 mRNA vaccine and 15-µg of mRNA encoding the spike protein of the Omicron BA.4/BA.5 subvarian
-
-
The 11th Shanghai New Customization Week Opens, Taking Oriental Life Aesthetics to Greater Heights
2022-11-17Source: Shanghai International Fashion FederationOn the evening of 16 November, the 11th Shanghai New Customization Week (SNCW) organized by the Shanghai International Fashion Federation (SHIFF) kicked off at the Fosun Foundation (Shanghai) in the Grand Yuyuan. Themed around "Boundless Oriental Beauty", this year's SNCW runs until 20 November, covering a series of fashi
-
-
Fosun Pharma, Yuyuan, Nanjing Iron & Steel, and Hainan Mining Hold a Joint 2022 Third Quarter Results Presentation
2022-11-10On 10 November 2022, four A-share subsidiaries of Fosun including Fosun Pharma, Yuyuan, Nanjing Iron & Steel, and Hainan Mining held a joint 2022 third quarter results presentation at the Shanghai Stock Exchange to share their results highlights and latest business development, and communicate on issues that investors are concerned about. The p